Regeneron antibody earns nod for rare cholesterol disorder — but it ain't cheap
Regeneron has a new approved drug to add to its stable of monoclonal antibodies.
The FDA gave the thumbs-up to the biotech’s evinacumab, to be …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
